Emmanuel Roilides
Impact in
- Infectious Diseases top 0.02%
- Antifungal resistance and susceptibility
Papers in
-
- Antifungal resistance and susceptibility 234
-
- Antibiotic Resistance in Bacteria 48
- Co-authors
- Thomas J. WalshCharalampos AntachopoulosG. PetrikkosAnna SkiadaAndreas H. GrollP A PizzoDimitrios P. KontoyiannisAspasia Katragkou
- Journals
- Antimicrobial Agents and Chemotherapy (34 papers)The Pediatric Infectious Disease Journal (34 papers)Medical Mycology (25 papers)Mycoses (19 papers)Clinical Infectious Diseases (15 papers)
- Partner nations
- GreeceUnited StatesUnited Kingdom
In The Last Decade
Emmanuel Roilides
421 papers receiving 15.4k citations
Hit Papers
Peers
Comparison fields: 5 of 167
- Infectious Diseases 10.7k
- Applied Microbiology and Biotechnology 553
- Epidemiology 9.3k
- Molecular Medicine 1.3k
- Small Animals 1.3k
Countries citing papers authored by Emmanuel Roilides
This map shows the geographic impact of Emmanuel Roilides's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emmanuel Roilides with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emmanuel Roilides more than expected).
Fields of papers citing papers by Emmanuel Roilides
This network shows the impact of papers produced by Emmanuel Roilides. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emmanuel Roilides. The network helps show where Emmanuel Roilides may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Emmanuel Roilides, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 2 | |
| 3 | 2024 | 5 | |
| 4 | 2024 | 4 | |
| 5 | 2023 | 6 | |
| 6 | 2023 | 2 | |
| 7 | 2023 | 3 | |
| 8 | 2023 | 2 | |
| 9 | 2022 | 13 | |
| 10 | 2021 | 0 | |
| 11 | 2021 | 0 | |
| 12 | 2019 | 2 | |
| 13 | 2019 | 9 | |
| 14 | 2019 | 42 | |
| 15 | 2018 | 14 | |
| 16 | 2018 | 38 | |
| 17 | 2018 | 50 | |
| 18 | 2016 | 110 | |
| 19 | 2015 | 13 | |
| 20 | 2009 | 262 |
About Emmanuel Roilides
Emmanuel Roilides is a scholar working on Infectious Diseases, Molecular Medicine, Applied Microbiology and Biotechnology, Epidemiology and Critical Care and Intensive Care Medicine, having authored 432 papers that have together received 15.8k indexed citations. Recurring topics across this work include Antifungal resistance and susceptibility (234 papers), Fungal Infections and Studies (166 papers), Antibiotic Resistance in Bacteria (48 papers), Antibiotics Pharmacokinetics and Efficacy (47 papers), Pneumocystis jirovecii pneumonia detection and treatment (38 papers), Pneumonia and Respiratory Infections (38 papers), Infectious Diseases and Mycology (28 papers) and Neutropenia and Cancer Infections (25 papers). The work is most often cited by research in Infectious Diseases (10.7k citations), Applied Microbiology and Biotechnology (553 citations), Epidemiology (9.3k citations), Molecular Medicine (1.3k citations) and Small Animals (1.3k citations). Emmanuel Roilides has collaborated with scholars based in Greece, United States and United Kingdom. Frequent co-authors include Thomas J. Walsh, Charalampos Antachopoulos, G. Petrikkos, Anna Skiada, Andreas H. Groll, P A Pizzo, Dimitrios P. Kontoyiannis, Aspasia Katragkou, Olivier Lortholary and Joseph Meletiadis. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, The Pediatric Infectious Disease Journal, Medical Mycology, Mycoses and Clinical Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.